Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 35 citing articles:

Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk
Laura Pérez‐Alós, Cecilie Bo Hansen, José Juan Almagro Armenteros, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
The immunogenicity and reactogenicity of four COVID-19 booster vaccinations against SARS-CoV-2 variants following CoronaVac or ChAdOx1 nCoV-19 primary series
Nasikarn Angkasekwinai, Suvimol Niyomnaitham, Jaturong Sewatanon, et al.
Asian Pacific Journal of Allergy and Immunology (2023)
Open Access | Times Cited: 23
Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4+ and CD8+ T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
Alessandra Aiello, Andrea Coppola, Valentina Vanini, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 841-849
Open Access | Times Cited: 29
Testing for SARS-CoV-2: lessons learned and current use cases
Elitza S. Theel, James E. Kirby, Nira R. Pollock
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 5
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
Síle A. Johnson, Eloise Phillips, Sandra Adele, et al.
Clinical & Experimental Immunology (2023) Vol. 212, Iss. 3, pp. 249-261
Open Access | Times Cited: 13
Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity
Maria-Myrto Dourdouna, Elizabeth‐Barbara Tatsi, Vasiliki Syriopoulou, et al.
Diagnostic Microbiology and Infectious Disease (2023) Vol. 106, Iss. 3, pp. 115948-115948
Open Access | Times Cited: 10
Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents
Tobias Rothoeft, Claudia S. Maier, A Talarico, et al.
Infection (2024) Vol. 52, Iss. 4, pp. 1449-1458
Open Access | Times Cited: 2
Cell immunity to SARS-CoV-2 after natural infection and/or different vaccination regimens
Esther Culebras, Mercedes Martínez, Consuelo Novella, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and Vaccination
Emma Leacy, Jia Wei Teh, Aoife M. O’Rourke, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5239-5239
Open Access | Times Cited: 2
Comparison of Two Commercially Available Interferon-γ Release Assays for T-Cell-Mediated Immunity and Evaluation of Humoral Immunity against SARS-CoV-2 in Healthcare Workers
Alexandra Lochmanová, Jan Martínek, Hana Tomášková, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 637-637
Open Access | Times Cited: 7
Skewed fate and hematopoiesis of CD34+ HSPCs in umbilical cord blood amid the COVID-19 pandemic
Benjamin K. Estep, Charles J. Kuhlmann, Satoru Osuka, et al.
iScience (2022) Vol. 25, Iss. 12, pp. 105544-105544
Open Access | Times Cited: 11
Improved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set
Lydia Lamara Mahammed, Kahina Bensaid, Sarah Ait-Seddik, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1179-1179
Open Access | Times Cited: 5
Controlling the Quality of Nanodrugs According to Their New Property—Radiothermal Emission
Gleb V. Petrov, DARIA A. GALKINA, Alena M. Koldina, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 180-180
Open Access | Times Cited: 1
Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations
Elizabeth Titova, Veronica W. Kan, Tara Lozy, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 1
Application of Interferon-γ Release Assay in the Assessment of T-Cell Immunity to SARS-CoV-2 Antigens in the Cohort of Pediatric Patients with Juvenile Idiopathic Arthritis
Katarzyna Kapten, Krzysztof Orczyk, Elżbieta Smolewska
Children (2024) Vol. 11, Iss. 6, pp. 736-736
Open Access | Times Cited: 1
Humoral and Cellular Response after mRNA Vaccination in Nursing Homes: Influence of Age and of History of COVID-19
Jesús San Román, Francisco Javier Candel, Juan Carlos Sanz, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 383-383
Open Access | Times Cited: 8
Assessment of the Immune Response in Patients with Insulin Resistance, Obesity, and Diabetes to COVID-19 Vaccination
Jędrzej Warpechowski, Paula Leszczyńska, Dominika Juchnicka, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1203-1203
Open Access | Times Cited: 4
T-Cell Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Measured by an Interferon-γ Release Assay Is Strongly Associated With Patient Outcomes in Vaccinated Persons Hospitalized With Delta or Omicron Variants
Marta Fernández‐González, Vanesa Agulló, José Alberto García, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 9, pp. 1240-1252
Open Access | Times Cited: 3
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021
Kento T. Abe, Bhavisha Rathod, Karen Colwill, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 5
„A baj nem jár egyedül” – de novo diagnosztizált myeloma multiplex invazív Streptococcus pneumoniae fertőzéssel citokinviharral szövődött COVID–19-ben
Dorina Korózs, Nóra Jenőfi, Bálint Gergely Szabó, et al.
Orvosi Hetilap (2023) Vol. 164, Iss. 20, pp. 763-769
Open Access | Times Cited: 2
Factors Associated with SARS-CoV-2 Infection in Fully Vaccinated Nursing Home Residents and Workers
Jesús Mateos‐Nozal, Mario Rodríguez-Domínguez, Jesús San Román, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 186-186
Open Access
IFN-γ derived from activated human CD4+ T cells inhibits the replication of SARS-CoV-2 depending on cell-type and viral strain
Jun Shimizu, Tadahiro Sasaki, Guang Han Ong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Longitudinal Comparison of Three T-Cell Assays and Three Antibody Assays Against SARS-CoV-2 Following Homologous mRNA-1273/mRNA-1273/mRNA-1273 and Heterologous ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naïve Healthcare Workers
Hyeyoung Lee, Geon Young Ko, Ji‐Hyun Lee, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1350-1350
Open Access
Immune Response Dynamics to SARS-CoV-2 in the Albanian Population: A Study on T-Cell and Antibody Interactions During the Transition From Pandemic to Endemic Phase
Genc Sulcebe, Erkena Shyti, Jonida Dashi-Pasholli, et al.
Infectious Diseases & Immunity (2024)
Open Access
Comparison of different T cell assays for the retrospective determination of SARS-CoV-2 infection
Benjamin A. Krishna, Marina Metaxaki, Marianne Perera, et al.
Journal of General Virology (2024) Vol. 105, Iss. 12
Open Access
Page 1 - Next Page

Scroll to top